Your SlideShare is downloading. ×
Rational use of blood component
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Rational use of blood component

3,405

Published on

Review general usage of blood components and basic transfusion medicine.

Review general usage of blood components and basic transfusion medicine.

Published in: Health & Medicine, Business
0 Comments
5 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
3,405
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
238
Comments
0
Likes
5
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • \n
  • Transcript

    • 1. RATIONAL BLOOD USE.. ...and its components.
    • 2. TOPIC• Historical interest• Blood process• Blood product• Indication• Special consideration• Complication
    • 3. HISTORICAL INTEREST
    • 4. THE FIRST BLOODTRANSFUSION ATTEMPT • In1492 "the harrowing story was told that, at the suggestion of a Jewish physician, the blood of three boys was infused into the dying pontiff ’s mouth (the concept of circulation and methods for intravenous access did not exist at that time). They were ten years old, and had been promised a ducat each. All three died." Diario della città di Roma di Stefano Infessura scribasenato. 15th cent.
    • 5. BLOOD AND CIRCULATION• In 1628 William Harvey published De Motu Cordis (On the Motion of the Heart and Blood) revealed the action of the heart pumping blood around the body in a circuit.
    • 6. TRANSFUSION ATTEMPTS• In 1667 Jean-Baptiste Denys, French physician, performed transfusion with sheeps and calfs blood.• In 1818 James Blundell, successfully performed transfusion for postpartum hemorrhage, using patients husbands blood.• In1905 George Washington Crile, co- founder of Cleveland Clinic, was the first surgeon who used direct blood transfusion in surgery.
    • 7. BLOOD GROUPING• In 1901, Karl Landsteiner discovered human blood groups. Blood transfusion had become a lot safer since then.
    • 8. DEVELOPMENT OF BLOOD BANKING• Anticoagulant was discovered in 1910, making the way to blood banking.• First stored blood was successfully transfused in 1916 by Oswald Hope Robertson, an English-born medical scientist, during World War I.• The first academic transfusion institution was found by Alexander Bogdanov in Moscow.• After Bogdanovs death Soviet established the worlds first blood bank in 1930s by Sergei Sergeevich Yudin at Nikolay Sklifosovskiy Institute.
    • 9. BLOOD PROCESSING
    • 10. HOW IS DONATED BLOOD PROCESSED?• Blood and blood components come from potential donors.• Wholeblood was used in first era of transfusion but blood components are now wildly used for better efficient management.
    • 11. LEUKOCYTE REDUCTION• WBC less than 5 x 106/unit*• Reduced febrile reaction risk yte oc ! Le uk d! duce• Reduced CMV transmission re• ReducedHLA- alloimmunization risk
    • 12. IRRADIATION • Inactivate donor’s T-cells • Reduced GVHD risk • Reduce shelf life to 28 days • Increased K+ leak
    • 13. SINGLE DONOR PRODUCT • Reduce donor exposure • Single HLA antigen
    • 14. BLOOD PRODUCT
    • 15. WHOLE BLOOD•Volume 350 or 450 ml•Contain red cell, white cells,platelets, and plasma•Stored at 2-6°c•No functional platelets andlabile factors•May indicated in neonatalblood exchange
    • 16. PACKED REDBLOOD CELL•Volume ~300 ml•Hct ~75%•Contain red cells, whitecells, small of plasma•Stored at 2-6°c•10ml/kg raise Hct ~10%
    • 17. PACKED REDBLOOD CELL•Volume ~300 ml•Hct ~75%•Contain red cells, whitecells, small of plasma•Stored at 2-6°c yte oc ! Le uk d!•10ml/kg raise Hct ~10% ce re du
    • 18. PACKED REDBLOOD CELL•Volume ~300 ml•Hct ~75%•Contain red cells, whitecells, small of plasma•Stored at 2-6°c yte oc ! Le uk d!•10ml/kg raise Hct ~10% ce re du
    • 19. PLATELETCONCENTRATE•Volume ~50 ml• Contain platelet 5.5 x 1010RBC 0.5 ml and white cells•Stored at 20-26°c withcontinuous rocking shelf•1 unit/10 kg raise platelet20,000-50,000 ml/mcL
    • 20. POOLEDLEUKOCYTE-POOR PLATELET•Made of 4 unit of wholeblood•Contain platelet 3 x 1011 andRBC 5 ml•Comparable to Plt. conc. 4-6units (6 - 8 units for SDP)
    • 21. POOLEDLEUKOCYTE-POOR PLATELET•Made of 4 unit of wholeblood•Contain platelet 3 x 1011 and yte oc !RBC 5 ml Le uk d! duce•Comparable to Plt. conc. 4-6 reunits (6 - 8 units for SDP)
    • 22. POOLEDLEUKOCYTE-POOR PLATELET•Made of 4 unit of wholeblood•Contain platelet 3 x 1011 and yte oc !RBC 5 ml Le uk d! duce•Comparable to Plt. conc. 4-6 reunits (6 - 8 units for SDP)
    • 23. FRESH FROZENPLASMA•Volume 250 ml•Contain all coagulationfactor•10-15 ml/kg raise factor~25%•Stored at -18°c
    • 24. CRYOPRECIPITATE•Volume 15 ml•Contain factor VIII, XIII,von Willebrand factor,fibrinogen•1-2 units/ 10 kg raisefibrinogen 100 mg/dL•Not require groupmatching
    • 25. INDICATION
    • 26. THRESHOLD FOR RBC TRANSFUSION• Hb < 7 g/dL in general patient• Hb < 10 g/dL in patient with ischemic heart disease• Hb < 10 g/dL in pre-operative patient or bleeding patient*• In symptomatic or frail patient*
    • 27. PATIENT WHO SHOULD NOT BE TRANSFUSED• Nutritional anemia• Autoimmune hemolytic anemia• Patient with high peripheral blast count
    • 28. PLATELET REQUIREMENT• In bleeding patient: keep platelet > 50,000 - 80,000/mcL• Bleeding in vital organ: keep platelet > 100,000/mcL• In chronic thrombocytopenia: keep > 10,000/mcL• In DIC keep platelet > 20,000/mcL• In APL keep platelet > 30,000 - 50,000/mcL
    • 29. PLATELET CONTRAINDICATE• Thrombotic thrombocytopenic purpura• Heparin induced thrombocytopenia• Disseminated intravascular coagulation without bleeding*
    • 30. FRESH FROZEN PLASMA• Ingeneral each milliliter of plasma count as 100% factor activity 100% + 0% = 50% Hemostat level = 40%• Ifcoagulogram ≤1.5 times of normal, other causes of abnormal bleeding should be sought
    • 31. CRYOPRECIPITATE• Use for replacing factor VIII, factor XIII, von Willebrand factor, fibrinogen
    • 32. SPACIAL CONSIDERATION
    • 33. SPACIAL CONSIDERATION• Rh negative patient• Mismatch transfusion• Platelet refractoriness• Massive transfusion
    • 34. RH NEGATIVE• Rh negative is determined by absence of D antigen• Antibody occur 4 - 8 wks after expose to D antigen• Rh negative person should receive only Rh negative blood• Platelets have no Rh antigen but contaminated RBC can induce antibody
    • 35. PLATELET TRANSFUSION IN RH NEGATIVE• Check if patient already have Rh antibody• Give anti-D IgG before or within 72 hr after platelet transfusion• 100 units can neutralize RBC 5 ml• 300 units can neutralize Plt. conc. 30 units or LPPC 3 units
    • 36. MISMATCH TRANSFUSION• Transfuse packed red cell without foreign antigen to avoid major mismatch reaction• Transfuse plasma without offending antibody to avoid minor mismatch reaction• Platelet is considered as plasma due to high plasma content • Platelet recovery will be less than expected
    • 37. TRANSFUSION COMPATIBILITYBlood group Compatible Compatible A RBC A, O Plt. & FFP A, AB B B, O B, AB AB AB, A, B, O AB O O O, A, B, AB
    • 38. PLATELET REFRACTORINESS• Corrected count increment (CCI) < 3,000/mcL• Corrected count increment = (Pre - Post) x Body surface area Transfused platelet
    • 39. PLATELET REFRACTORINESS• Immune • Non-immune•    Alloimmunization •    Infection, fever•    Autoimmune •    Hypersplenism•    Drug-related antibody •    DIC•    ABO incompatibility •    BMT patient •    Ampho B •    etc.
    • 40. MASSIVE TRANSFUSION• 1 Total blood volume within 24 hr.• Keep platelet > 50,000/mcL• Keep coagulogram less than 1.5 times• Not recommend 1:1:1 transfusion protocol
    • 41. TRANSFUSION PRACTICE• Correct blood component processing• Correct sample taking and labeling• Correct crossmatch technique• Correct blood component label• Correct patient identification
    • 42. TRANSFUSION PRACTICE• Check if bags are in good condition • No leakage • No fibrin clot• Recordvital sign at before, start, 15 min after, 1 hr after, and 4 hr after transfusion
    • 43. COMPLICATION OF BLOOD TRANSFUSION
    • 44. COMPLICATION OF BLOOD TRANSFUSION• Immediate hemolytic • Febrilenonhemolytic transfusion reaction transfusion reaction• Delayed hemolytic • Transfusion-related acute transfusion reaction lung injury• Bacterial contamination • Transfusion-related graft- versus-host disease• Allergic reaction • Post transfusion purpura
    • 45. IMMEDIATE HEMOLYTIC TRANSFUSION REACTION• ABO incompatibility is the most common cause• Can be fatal even 30 ml of incompatible blood• Intravascular hemolysis• Renal failure• Shock
    • 46. IMMEDIATE HEMOLYTIC TRANSFUSION REACTION• Chill • Dark urine• Fever • Shock• Flank • DIC pain • Red serum
    • 47. IMMEDIATE HEMOLYTICTRANSFUSION REACTION
    • 48. IMMEDIATE HEMOLYTICTRANSFUSION REACTION
    • 49. IMMEDIATE HEMOLYTICTRANSFUSION REACTION
    • 50. IMMEDIATE HEMOLYTICTRANSFUSION REACTION C5 C3
    • 51. IMMEDIATE HEMOLYTICTRANSFUSION REACTION CC5 5b a CC3 3b a
    • 52. IMMEDIATE HEMOLYTICTRANSFUSION REACTION a CC5 5b C5 CC3 3b C3a
    • 53. IMMEDIATE HEMOLYTICTRANSFUSION REACTION a CC5 5b C5 CC3 3b C3a anaphylotoxic activity
    • 54. IMMEDIATE HEMOLYTICTRANSFUSION REACTION FXII generate bradykinin histamine serotonin a CC5 5b C5 CC3 3b C3a anaphylotoxic activity
    • 55. IMMEDIATE HEMOLYTICTRANSFUSION REACTION c k ! FXII generate bradykinin Sho histamine serotonin a CC5 5b C5 CC3 3b C3a anaphylotoxic activity
    • 56. IMMEDIATE HEMOLYTIC TRANSFUSION REACTION• IV fluid maintain urine output 100 ml/hr • Furosemide or mannitol if needed• Maintain blood pressure• Check label• Re-crossmatch on pre- and post-transfusion samples• Prevention future event
    • 57. DELAYED HEMOLYTIC TRANSFUSION REACTION• Occur 1 wk after transfusion• Anamnestic immune response• Extravascular hemolysis• Usually subtle symptoms• Antibody gradually decrease after expose to antigen
    • 58. BACTERIAL CONTAMINATION• Platelet prone to have bacterial overgrowth enterocollitca can• Yersinia grow at 6°c etc.• Antibioticshould be started if suspected bacterial contamination
    • 59. ALLERGIC REACTION• Allergic to plasma protein of donor• Can give antihistamine to relieve symptoms• In IgA deficiency patient should avoid plasma product
    • 60. FEBRILE NONHEMOLYTIC TRANSFUSION REACTION• Fever• Caused by alloantibody to HLA antigen on Plt. or WBC• No specific treatment• Must differentiate from other causes of fever
    • 61. TRANSFUSION RELATED ACUTE LUNG INJURY• TRALI• Causeby alloantibody from donor to WBC of recipient• Occur within 6 hours after transfusion• Symptoms is the same as ARDS
    • 62. TRANSFUSION RELATEDGRAFT-VERSUS-HOST DISEASE• Cause by engraftment of donor T-cells• Damage to epithelium and bone marrow• Fatal condition• Prevent with irradiation of blood component with T-cells
    • 63. Recognize T T Engraft Reject Recipient tissue HLA antigenT T-cells Transfusion related GVHD
    • 64. PATIENT IN RISK OF GVHD FROM TRANSFUSION• Bone marrow transplant patient• Intrauterine transfusion• Hx of fludarabine use (follicular lymphoma, CLL, AML)• HLA matched transfusion• Transfusion from relatives• Severe congenital immunodeficiency
    • 65. PROTOCOL FOR COMPLICATION EPISODE Chill, fever, rash, flank pain, chest tightness,vital sign change, alteration of consciousness, dark urine Stop transfusion! Check vital sign, load IV fluid maintain BP and urine output Aware of renal complication
    • 66. PROTOCOL FOR COMPLICATION EPISODE Check label and patient’s identificationDraw blood from patient Examine transfusing bloodCentrifuge for serum color Blood group Coomb test Re-crossmatch with pre- and Blood group post-transfusion samples Hemoculture Hemoculture
    • 67. PROTOCOL FORCOMPLICATION EPISODE Identify defect in the system No accusing investigation Solution Prevent future event
    • 68. FIN

    ×